WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WVE WAVE Life Sciences

Trading 12-11 14:58:45 EST

17.39

-2.84

-14.04%

High20.00	Low16.66	Vol12.28M
Open19.54	D1 Closing20.23	Amplitude16.51%
Mkt Cap2.90B	Tradable Cap1.68B	Total Shares167.00M
T/O217.16M	T/O Rate12.69%	Tradable Shares96.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WVE","market":"US","secType":"STK","nameCN":"WAVE Life Sciences","latestPrice":17.3899,"timestamp":1765483123349,"preClose":20.23,"halted":0,"volume":12280485,"delay":0,"floatShares":96808300,"shares":167000000,"eps":-0.743552,"marketStatus":"Trading","change":-2.8401,"latestTime":"12-11 14:58:45 EST","open":19.5413,"high":20,"low":16.66,"amount":217156295.193915,"amplitude":0.165101,"askPrice":17.39,"askSize":207,"bidPrice":17.37,"bidSize":1306,"shortable":0,"etf":0,"ttmEps":-0.743552,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1447218000000,"exchange":"NASDAQ","adjPreClose":20.23,"preHourTrading":{"tag":"盘前","latestPrice":19.6089,"preClose":20.23,"latestTime":"09:29 EST","volume":58936,"amount":1148688.807584,"timestamp":1765463357914},"postHourTrading":{"tag":"盘后","latestPrice":19.9424,"preClose":20.23,"latestTime":"19:59 EST","volume":73182,"amount":1468813.0743,"timestamp":1765414749925},"volumeRatio":0.34995,"optionData":{"bulkOrders":[{"symbol":"WVE","call":true,"expireDate":1768539600000,"strike":"20.0","timestamp":1765468414013,"price":1,"volume":1500,"amount":150000,"type":"+"}]},"impliedVol":1.0028,"impliedVolPercentile":0.516},"requestUrl":"/m/hq/s/WVE/tweets","defaultTab":"tweets","newsList":[{"id":"2590563578","title":"Wave Life Sciences Director Mark Corrigan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590563578","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590563578?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:45","pubTimestamp":1765421146,"startTime":"0","endTime":"0","summary":"Mark Corrigan, Director at Wave Life Sciences Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b038ff687efe36210ac6c40aceddb1eb","theme_name":"🔥TrendingNo.29 · Wave Life Sciences and Guardant Health Executives Report Disposal of Common Shares on December 10, 2025","theme_type":2,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL3xg6Ln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Wave Life Sciences Director Mark Corrigan Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590095533","title":"Wave Life Sciences Shares Drop After Equity Offering Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2590095533","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590095533?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:52","pubTimestamp":1765378320,"startTime":"0","endTime":"0","summary":"Wave Life Sciences' shares fell sharply after the clinical-stage biotechnology company priced an upsized $350 million equity raising.The shares were down 10% at $19.09 in early trading Wednesday, narrowing the advance in 2025 to 54%.Wave Life late Tuesday said an underwritten public offering of 15.8 million of its shares was priced at $19 apiece, along with warrants to buy 2.63 million shares at $18.9999 each.The company granted the underwriters a 30-day option to buy up to an additional 2.76 million of its shares on the same terms.Wave Life on Monday launched an offering of $250 million of its shares and warrants.The offering is expected to close on or about Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4215","BK4585","BK4007","WVE","EQR","BK4588"],"gpt_icon":1},{"id":"2590374381","title":"BRIEF-Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374381","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590374381?lang=en_us&edition=fundamental","pubTime":"2025-12-10 10:52","pubTimestamp":1765335122,"startTime":"0","endTime":"0","summary":"BRIEF-Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per ShareDec 9 (Reuters) - WAVE Life Sciences Ltd WVE.O:WAVE LIFE SCIENCES PRICES UPSIZED $350 MILLION PUBLIC OFFERING O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WVE","BK4007"],"gpt_icon":1},{"id":"2590374809","title":"Wave Life Sciences Ltd -  Prices Public Offering of 15.8 Mln  Shares at a Price of $19.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590374809?lang=en_us&edition=fundamental","pubTime":"2025-12-10 10:50","pubTimestamp":1765335008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0J5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"2590291443","title":"Wave Life Sciences Adds to Gains After Analysts Raise Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2590291443","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590291443?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:15","pubTimestamp":1765311300,"startTime":"0","endTime":"0","summary":"Wave Life Sciences shares, which skyrocketed Monday on favorable interim Phase 1 data for weight loss drug WVE-007, gained on Tuesday after analysts raised price targets.Shares rose 147% to $18.52 on Monday, and were recently up 14% to $21.18. They touched a 52-week high of $21.73.Wells Fargo raised its price target to $29 from $16, while RBC Capital raised its target to $27 from $9. Citigroup, Canaccord Genuity, Clear Street and Cantor Fitzgerald also increased their price targets.Wave Life Sciences said that following a single subcutaneous 240-mg dose, WVE-007 improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"2590329183","title":"Wave Life Sciences Shares Rise After RBC Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2590329183","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590329183?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:09","pubTimestamp":1765310959,"startTime":"0","endTime":"0","summary":"Wave Life Sciences  shares rose more than 14% in recent Tuesday trading after RBC Capital Markets upgraded the stock to outperform from sector perform and raised its price target to $27 from $9.Trading volume stood at over 23.7 million compared with a daily average of about 4.9 million.Price: 21.16, Change: +2.64, Percent Change: +14.25","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"830c8330d409845e04ca5a0e66727d79","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"2590217326","title":"What's Going On With Wave Life Sciences Stock Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590217326","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590217326?lang=en_us&edition=fundamental","pubTime":"2025-12-10 03:11","pubTimestamp":1765307460,"startTime":"0","endTime":"0","summary":"Wave Life Sciences rises after new WVE-007 weight-loss data and multiple analyst upgrades, alongside a $250 million offering announcement.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/09/Why-Diet-Soda-Might-Harm.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/09/Why-Diet-Soda-Might-Harm.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49289117/whats-going-on-with-wave-life-sciences-stock-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49289117/whats-going-on-with-wave-life-sciences-stock-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","WVE"],"gpt_icon":1},{"id":"1148703051","title":"Stock Track | WAVE Life Sciences Soars 13.39% Intraday on Positive Obesity Drug Data and Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1148703051","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148703051?lang=en_us&edition=fundamental","pubTime":"2025-12-10 02:46","pubTimestamp":1765305984,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) surged 13.39% intraday on Tuesday, continuing its upward momentum following promising interim Phase 1 trial results for its investigational obesity therapy, WVE-007.The data...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"555c7582c603e30adb6ccf2ae0112896","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"2590334503","title":"Wave Life Sciences Is Maintained at Buy by Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2590334503","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590334503?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:30","pubTimestamp":1765283400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WVE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 07:30 ET (12:30 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","WVE"],"gpt_icon":0},{"id":"1194446149","title":"Stock Track | WAVE Life Sciences Soars 5.18% in Pre-Market on Positive Obesity Drug Trial Results and Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1194446149","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194446149?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:48","pubTimestamp":1765280908,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) surged 5.18% in pre-market trading following the release of promising interim Phase 1 trial data for its investigational obesity therapy, WVE-007. The results showed a 9.4%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0d850c2dc13857825ff7bfc8889a623d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"2590348513","title":"RBC Upgrades Wave Life Sciences to Outperform From Sector Perform, Boosts Price Target to $27 From $9, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2590348513","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590348513?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:28","pubTimestamp":1765279683,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) has an average rating of buy and mean price target of $28.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"2590310019","title":"Wave Life Sciences Ltd : Citigroup Raises Target Price to $30 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2590310019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590310019?lang=en_us&edition=fundamental","pubTime":"2025-12-09 19:18","pubTimestamp":1765279126,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF06R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"1195100840","title":"Premarket Movers | Ares Management Jumps over 8% on S&P 500 Inclusion; Wave Life Sciences Rises Another 4%; WBD Pops Nearly 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1195100840","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195100840?lang=en_us&edition=fundamental","pubTime":"2025-12-09 17:11","pubTimestamp":1765271514,"startTime":"0","endTime":"0","summary":"Shares of $Ares Management(ARES)$  jumped over 8% in premarket trading. Ares Management will join the S&P 500 before market open on December 11, S&P Dow Jones Indices said on Monday, becoming the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"553b3113a8a6433b16057fe4e53db338","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WBD","WVE","ARES","SEZL","VITL"],"gpt_icon":0},{"id":"2590360258","title":"Nvidia, AMD, Wave Life Sciences, Toll Brothers And Carvana: Why These 5 Stocks Are On Investors' Radars Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2590360258","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590360258?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:17","pubTimestamp":1765243020,"startTime":"0","endTime":"0","summary":"NVDA, AMD, WVE, TOL, CVNA were among the stocks seen trending on Monday, Dec. 8, 2025.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/08/Creative-Glowing-Candlestick-Forex-Chart.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/08/Creative-Glowing-Candlestick-Forex-Chart.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/25/12/49272368/nvidia-amd-wave-life-sciences-toll-brothers-and-carvana-why-these-5-stocks-are-on-investors-radars-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/12/49272368/nvidia-amd-wave-life-sciences-toll-brothers-and-carvana-why-these-5-stocks-are-on-investors-radars-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU2360107168.USD","LU1778281490.HKD","SG9999015952.SGD","LU0109391861.USD","LU0077335932.USD","LU0082616367.USD","LU1861127337.USD","LU1551013425.SGD","LU1935043023.USD","LU0494093205.USD","LU1791710400.SGD","LU2361044949.HKD","LU0069063385.USD","BK4550","IE0005OL40V9.USD","BK4551","BK4587","LU2168564222.USD","LU0354030438.USD","LU0985320562.USD","LU2322448791.USD","LU0203201768.USD","LU0061474705.USD","LU2125909593.SGD","IE00BMPRXR70.SGD","BK4512","LU0820561818.USD","BK4573","IE0004445239.USD","IE00B1BXHZ80.USD","LU0820561909.HKD","LU0029864427.USD","IE0004445015.USD","LU2756315318.SGD","LU1868836914.USD","LU1069344957.HKD","LU0158827948.USD","LU0672654240.SGD","LU1116320737.USD","LU1429558221.USD","LU0342679015.USD","LU2236285917.USD","IE00BMPRXQ63.HKD","LU2403377893.USD","LU2237438978.USD","LU1712237335.SGD","LU0889565833.HKD","LU1934455194.USD","LU1935042991.SGD","LU1145028129.USD","LU2083900584.USD","LU0234570918.USD","IE00BN29S564.USD","BK4567","LU0308772762.SGD","LU2089283258.USD","LU1815336760.USD","LU0128525929.USD","LU2272731782.SGD","SG9999014575.USD","LU2249611893.SGD","LU0274383776.USD","LU0823434583.USD","SG9999015358.SGD","LU2473716301.USD","LU0210528500.USD","NVDY","LU1861215975.USD","LU2290526834.HKD","LU2360032135.SGD","SG9999014898.SGD","BK4533","LU0965509283.SGD","LU2491050154.USD","LU0079474960.USD","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0127658192.USD","LU1791710582.SGD","LU1923623000.USD","LU1821325948.USD","SG9999017495.SGD","LU0256863811.USD","BK4529","BK4585","LU2065170008.USD","LU0211327993.USD","NVIW.SI","LU0640476718.USD","NVDS.UK","LU0256863902.USD","LU0823414551.USD","LU1280957306.USD","IE00BMPRXN33.USD","LU2360106780.USD","LU1548497426.USD","LU2452424414.USD","LU0345769631.USD","LU2294711713.HKD","LU2420271590.USD","LU0472753341.HKD","BK4614","BK4579","LU0683600562.USD","LU0251132253.USD","SG9999002224.SGD","IE000KEQY171.SGD","LU1267930490.SGD","LU1992135472.HKD","LU2247934214.USD","HK0000320264.USD","LU1923622291.USD","LU0215105999.USD","IE000ITXATA3.USD","LU0109392836.USD","IE00BDCRKT87.USD","LU0868494617.USD","LU2250418816.HKD","LU0198837287.USD","LU0096362180.USD","LU0528227936.USD","LU0823421416.USD","IE00B4YYXB79.USD","BK4543","LU1852331112.SGD","LU2213496289.HKD","SG9999014567.USD","LU2125909916.SGD","SG9999001424.SGD","LU0708995401.HKD","LU2168564495.EUR","BK4532","LU0868494708.USD","LU2271345857.HKD","LU0061474960.USD","LU1066051225.USD","BK4548","LU2458330169.SGD","HK0000306701.USD","LU2357125470.USD","LU2125909247.SGD","IE00B5949003.HKD","LU0289960550.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","SG9999014906.USD","IE000YTNTUN2.SGD","LU0266013472.USD","LU1323610961.USD","LU2063271972.USD","LU2461242641.AUD","LU2108987350.USD","BK4534","LU0689626769.HKD","IE00BK4W5L77.USD","LU1435385759.SGD","LU2505996681.GBP","SGXZ99366536.SGD","LU0175139822.USD","SGXZ51526630.SGD","LU0942090050.USD","LU0689472784.USD","LU2065171402.SGD","LU1037948541.HKD","LU2106854487.HKD","LU2168564149.EUR","LU2931357623.SGD","LU1803068979.SGD","LU2602419157.SGD","WVE","LU2054465674.USD","LU2237957902.USD","LU2023251221.USD","LU0965509010.AUD","BK4612","SGXZ31699556.SGD","IE00B3SWFQ91.USD","LU1623119135.USD","NVDD","LU2125154935.USD","LU0957791311.USD","LU0310800379.SGD","LU2326559502.SGD","LU2746668974.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU1989772923.USD","LU0345768153.USD","LU1989764664.SGD","LU1064131342.USD","LU1066051498.USD","LU2125909759.SGD","LU0276348264.USD","LU0170899867.USD","LU1992135399.USD","LU1551013342.USD","IE00BDRTCR15.USD","LU1804176565.USD","LU1951200564.SGD","IE00B19Z8W00.USD","LU0345770308.USD","LU1861559042.SGD","LU0053666078.USD","LU2433249047.HKD","LU2087625088.SGD","IE0004086264.USD","BK4549","LU0786609619.USD","LU1914381329.SGD","IE00BD6J9T35.USD","LU1988902786.USD","BK4141","BK4598","LU1880398554.USD","LU0056508442.USD","LU0466842654.USD","LU1868836591.USD","LU1066053197.SGD","IE00BHPRN162.USD","LU2417539215.USD","LU0708994859.HKD","LU0006306889.USD","LU2065171311.SGD","LU2462157665.USD","NVDX","LU1232071149.USD","LU0943347566.SGD","LU1983260115.SGD","LU1633808545.USD","LU2092627202.USD","LU2265009873.SGD","SG9999014542.SGD","LU0187121727.USD","SGXZ23171101.USD","IE0004091025.USD","LU0225283273.USD","CVNA","LU0557290698.USD","LU2463028550.USD","LU0823434740.USD","LU0267386448.USD","LU1267930730.SGD","BK4575","LU2491050071.SGD","LU2592432038.USD","LU0080751232.USD","SG9999004303.SGD","LU2272731865.HKD","LU0211328371.USD","IE0001KFT4U8.USD","LU1037948897.HKD","LU0347712357.USD","IE00BQXX3F31.USD","LU0511384066.AUD","LU0154236417.USD","SG9999018857.SGD","BK4566","LU2191332357.HKD","LU1366333091.USD","LU2168564065.EUR","LU2746668461.USD","LU1974910355.USD","LU1267930573.SGD","SG9999014559.SGD","LU0642271901.SGD","LU1366192091.USD","LU0061475181.USD","SG9999014914.USD","IE00BZ1G4Q59.USD","SNVD.UK","LU1868836757.USD","BK4592","LU2543165471.USD","LU2458330243.SGD","LU2471134523.USD","LU2750360997.AUD","HK0000320223.HKD","LU0124676726.USD","LU2430703178.SGD","GB00BDT5M118.USD","LU1303367103.USD","LU2098885051.SGD","LU1244550577.SGD","IE00BKPKM429.USD","LU1720051108.HKD","NVDA","LU1935042488.USD","LU2111349929.HKD","LU2077746001.SGD","LU0289739343.SGD","LU2087621335.USD","LU1868837300.USD","LU1951198990.SGD","LU1244550221.USD","SG9999015341.SGD","LU1242518857.USD","LU1496350171.SGD","LU2023250330.USD","SG9999015945.SGD","IE00BJJMRY28.SGD","NVD","LU0316494557.USD","LU0820562030.AUD","NVD2.UK","LU2065169927.USD","LU0210536198.USD","LU2896262040.SGD","SG9999002232.USD","NVDS","IE0034235188.USD","LU2506951792.HKD","LU1244550494.USD","LU2860962120.EUR","LU2244417387.USD","LU0238689110.USD","LU0788109477.HKD","LU1720051017.SGD","IE00B19Z8X17.USD","LU1116320901.HKD","LU2089284900.SGD","LU0964807845.USD","LU1917777945.USD","LU0354030511.USD","LU1642822529.SGD","LU0882574139.USD","LU0719512351.SGD","LU2322448957.HKD","LU1066051811.HKD","LU1316542783.SGD","LU2097344431.USD","LU0048584097.USD","LU0957808578.USD","IE00BZ199S13.USD","IE0003U64NQ7.SGD","IE0034235303.USD","LU0096364046.USD","LU0070217475.USD","LU2756315664.SGD","LU1815333072.USD","BK4088","IE00BYXW3230.USD","LU2552382132.HKD","SG9999000418.SGD","LU2264538146.SGD","IE00BJTD4V19.USD","LU1496350502.SGD","LU0476273544.USD","LU0823414478.USD","IE00B3M56506.USD","LU1868837136.USD","LU0234572021.USD","LU0444973449.USD","LU2242650005.HKD","LU2487616109.SGD","LU1718418525.SGD","LU1119994496.HKD","IE00BFSS8Q28.SGD","LU0965508806.USD","LU2471134879.HKD","LU2381873111.SGD","IE00BJLML261.HKD","LU2092937148.SGD","BK4608","LU1935043536.SGD","LU0353189680.USD","LU0345770993.USD","LU0320765059.SGD","LU0444971666.USD","LU2168563687.JPY","LU0106261372.USD","LU1861558580.USD","LU2286300806.USD","LU1035775433.USD","LU1674673428.USD","LU0158827781.USD","SG9999015986.USD","HK0000306685.HKD","IE00B1XK9C88.USD","LU1935042215.USD","BK4503","IE00BJJMRX11.SGD","LU1934455277.USD","IE0009356076.USD","TOL","LU1934455863.HKD","LU0097036916.USD","LU1629891620.HKD","LU0072462426.USD","BK4554","LU0210533765.USD","SG9999014880.SGD","LU2456880835.USD","LU2552382058.USD","LU0787776722.HKD","LU1839511570.USD","LU2357305700.SGD","LU1721428933.USD","IE000W1ABFV2.USD","LU0724617625.USD","LU2471134952.CNY","LU2552382215.SGD","BK4588","LU1989772840.SGD","IE00BKDWB100.SGD","LU2471134796.USD","AMD","IE0034235295.USD","IE00B775H168.HKD","LU0157215616.USD","LU2211815571.USD","LU2413666699.HKD","NVDU","LU2413666426.HKD","LU2430703095.HKD","LU0057025933.USD","LU1880398471.USD","IE00BWXC8680.SGD","LU0081259029.USD","LU2430703251.USD","LU1861220033.SGD","LU2028103732.USD","LU0289961442.SGD","LU2750360641.GBP","LU2089985449.USD","LU0965509101.SGD","LU2237957811.SGD","LU0417517546.SGD","NVD3.UK","BK4581","LU2505996509.AUD","LU1989764748.USD","LU0823421333.USD","IE00BK4W5M84.HKD","LU0353189763.USD","BK4527","LU1923622614.USD","LU0345769128.USD","2NVD.UK","LU1084165304.USD","IE00BJTD4N35.SGD","IE00B19Z9505.USD","IE00B7KXQ091.USD","LU2272731600.USD","LU1571399168.USD","LU2491049909.HKD","IE00BKVL7J92.USD","LU2023250504.SGD","LU0310799852.SGD","LU0265550946.USD","LU0345768740.USD","3NVD.UK","BK4211","LU0390134368.USD","LU0323591593.USD","LU1814569148.SGD","LU0979878070.USD","LU1674673691.USD","LU0094547139.USD","IE0009G5SDU7.USD","LU0203202063.USD","LU0107464264.USD","LU2097344357.USD","LU1127390331.HKD","LU1261432733.SGD","LU2361044865.SGD","LU0054578231.USD","BK4214","LU2361045086.USD","LU0861579265.USD","LU2355687059.USD","LU0265550359.USD","BK4605","LU1699723380.USD","LU0348723411.USD","SGXZ81514606.USD","LU1242518931.SGD","LU2242649171.HKD","LU2125154778.USD"],"gpt_icon":1},{"id":"1173510050","title":"Stock Track | WAVE Life Sciences Soars 5.56% on Positive Phase 1 Obesity Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1173510050","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173510050?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:08","pubTimestamp":1765242535,"startTime":"0","endTime":"0","summary":"WAVE Life Sciences (WVE) saw its stock surge 5.56% intraday on Monday following the release of promising interim data from its Phase 1 trial for WVE-007, an investigational obesity treatment. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"cb02a08a52cd2848e5afda66025e6225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WVE"],"gpt_icon":1},{"id":"1121475701","title":"Form 144 | WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis proposes to sell 483,602 Shares, with a total value of approximately $3.62 Million.","url":"https://stock-news.laohu8.com/highlight/detail?id=1121475701","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121475701?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:40","pubTimestamp":1765230020,"startTime":"0","endTime":"0","summary":"WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis plans to sell 483,602 common shares on December 8, 2025, with a total market value of approximately $3.62 million. Christopher Francis has made no sales in the past three months.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 144 | WAVE LIFE SCIENCES LTD.'s Officer Christopher Francis proposes to sell 483,602 Shares, with a total value of approximately $3.62 Million.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WVE"],"gpt_icon":0},{"id":"2590366583","title":"Wave Life Sciences Launches $250 Million Stock, Warrant Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590366583","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590366583?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:32","pubTimestamp":1765229548,"startTime":"0","endTime":"0","summary":"Wave Life Sciences  said late Monday it has launched a $250 million underwritten public offering of its ordinary shares, along with pre-funded warrants for select investors.The company said it plans to give underwriters a 30-day option to buy up to 15% of the shares and warrants offered on the same terms.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WVE","BK4007"],"gpt_icon":0},{"id":"2590655043","title":"Press Release: Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2590655043","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590655043?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:01","pubTimestamp":1765227660,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec. 08, 2025  -- Wave Life Sciences Ltd. , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health , announced today that it has commenced an underwritten public offering of $250 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave intends to grant the underwriters a 30-day option to purchase ordinary shares in an amount up to an additional 15% of the total amount of ordinary shares and shares underlying pre-funded warrants sold in the public offering on the same terms and conditions. All of the securities in the offering will be sold by Wave Life Sciences.Wave Life Sciences  is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave's RNA medicines platform, PRISM, combines multiple modalities, che","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","WVE","BK4007","R","BK4022"],"gpt_icon":0},{"id":"2590368764","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2590368764","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590368764?lang=en_us&edition=fundamental","pubTime":"2025-12-09 03:33","pubTimestamp":1765222388,"startTime":"0","endTime":"0","summary":"Top Wealth Group  disclosed late Friday a \"positive\" outlook for the financial year ending Dec. 31, anticipating net profits of not less than $4 million, rebounding from a $2 million loss a year ago.Shares of the company more than doubled as intraday trading volume catapulted to over 16.5 million from a daily average of about 249,000.Wave Life Sciences  said Monday that interim data from its phase 1 trial of WVE-007, an obesity treatment, showed improvements in body composition.The weight loss was similar to GLP-1, but without muscle loss, the company added.Shares of the company soared 140% as intraday trading volume surged to over 119 million from a daily average of roughly 2.6 million.Structure Therapeutics  disclosed on Monday that its obesity drug candidate aleniglipron achieved statistical significance in the phase 2b trial's primary and key secondary endpoints.Shares of the company surged 99% as intraday trading volume climbed to more than 16.1 million from a daily average of abo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4212","GPCR","BK4007","WVE","BK4599","TWG"],"gpt_icon":0},{"id":"2590236880","title":"Sector Update: Health Care Stocks Lower in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590236880","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590236880?lang=en_us&edition=fundamental","pubTime":"2025-12-09 02:43","pubTimestamp":1765219408,"startTime":"0","endTime":"0","summary":"Health care stocks declined Monday afternoon, with the NYSE Health Care Index down 1% and the Health Care Select Sector SPDR Fund  falling 1%.The iShares Biotechnology ETF  decreased 0.6%.In corporate news, STAAR Surgical  shares fell 4% after the company said Monday the go-shop period under its merger agreement with Alcon  has expired with no competing proposals received. Alcon was down 1.9%.PROCEPT BioRobotics  still has a large market opportunity for its aquablation technology to treat benign prostatic hyperplasia, but utilization growth has slowed, BofA Securities said in a research report. The brokerage downgraded the stock to neutral from buy and lowered its price target to $38 per share from $55. PROCEPT shares dropped 4.8%.Wave Life Sciences  shares soared 129% after the company said interim data from its phase 1 trial of WVE-007 to treat obesity showed improvements in body composition, with weight loss similar to GLP-1, but without muscle loss, at three months compared to base","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","XBI","STAA","BK4548","BK4007","BK4588","LU2324357040.USD","BK4534","GPCR","BK4198","BK4082","WVE","IBB","PRCT","ALC","BK4585","LABU","LU1804176565.USD","LU2265009873.SGD","BK4581","BK7094","ALC.AU","BK4599"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wavelifesciences.com","stockEarnings":[{"period":"1week","weight":1.8333},{"period":"1month","weight":1.8695},{"period":"3month","weight":1.8254},{"period":"6month","weight":1.9108},{"period":"1year","weight":0.3518},{"period":"ytd","weight":0.6354}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid (RNA) to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006, the SERPINA1 molecule for the treatment of Alpha-1 antitrypsin deficiency (AATD); and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders, including Alzheimer's and Parkinson's diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, and Glaxo Group Limited. The company was incorporated in 2012 and is based in Singapore.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.065604},{"month":2,"riseRate":0.7,"avgChangeRate":0.067262},{"month":3,"riseRate":0.3,"avgChangeRate":-0.085138},{"month":4,"riseRate":0.2,"avgChangeRate":-0.079373},{"month":5,"riseRate":0.5,"avgChangeRate":0.001154},{"month":6,"riseRate":0.5,"avgChangeRate":0.136995},{"month":7,"riseRate":0.5,"avgChangeRate":0.010097},{"month":8,"riseRate":0.8,"avgChangeRate":0.166322},{"month":9,"riseRate":0.4,"avgChangeRate":0.023822},{"month":10,"riseRate":0.5,"avgChangeRate":0.114526},{"month":11,"riseRate":0.6,"avgChangeRate":0.099642},{"month":12,"riseRate":0.181818,"avgChangeRate":0.04596}],"exchange":"NASDAQ","name":"WAVE Life Sciences","nameEN":"WAVE Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WAVE Life Sciences(WVE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WAVE Life Sciences,WVE,WAVE Life Sciences股票,WAVE Life Sciences股票老虎,WAVE Life Sciences股票老虎国际,WAVE Life Sciences行情,WAVE Life Sciences股票行情,WAVE Life Sciences股价,WAVE Life Sciences股市,WAVE Life Sciences股票价格,WAVE Life Sciences股票交易,WAVE Life Sciences股票购买,WAVE Life Sciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WAVE Life Sciences(WVE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WAVE Life Sciences(WVE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction